{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,4,25]],"date-time":"2026-04-25T00:40:57Z","timestamp":1777077657718,"version":"3.51.4"},"reference-count":84,"publisher":"Wiley","issue":"5","license":[{"start":{"date-parts":[[2007,11,14]],"date-time":"2007-11-14T00:00:00Z","timestamp":1194998400000},"content-version":"vor","delay-in-days":0,"URL":"http:\/\/onlinelibrary.wiley.com\/termsAndConditions#vor"}],"content-domain":{"domain":["onlinelibrary.wiley.com"],"crossmark-restriction":true},"short-container-title":["Br J Haematol"],"published-print":{"date-parts":[[2007,12]]},"abstract":"<jats:title>Summary<\/jats:title><jats:p>Monoclonal gammopathy of undetermined significance (MGUS) is characterized by a serum monoclonal protein &lt;30\u2003g\/l, &lt;10% plasma cells in the bone marrow, and absence of end\u2010organ damage (CRAB\u2013hyper<jats:styled-content>c<\/jats:styled-content>alcaemia, <jats:styled-content>r<\/jats:styled-content>enal insufficiency, <jats:styled-content>a<\/jats:styled-content>naemia, or <jats:styled-content>b<\/jats:styled-content>one lesions). MGUS is present in 3% of persons &gt;50\u2003years and in 5% &gt;70\u2003years of age. The risk of progression to multiple myeloma (MM) or a related disorder is 1% per year. Patients with risk factors consisting of an abnormal serum free light chain ratio, non\u2010immunoglobulin G (IgG) MGUS, and an elevated serum M protein \u226515\u2003g\/l had a risk of progression at 20\u2003years of 58%, compared with 37% with two risk factors present, 21% with one risk factor present, and 5% when none of the risk factors were present. Smouldering (asymptomatic) multiple myeloma is characterized by having a serum IgG or IgA monoclonal protein of 30\u2003g\/l or higher and\/or 10% or more plasma cells in the bone marrow but no evidence of end\u2010organ damage. The cumulative probability of progression to active MM or amyloidosis was 51% at 5\u2003years, 66% at 10\u2003years and 73% at 15\u2003years; the median time to progression was 4\u00b78\u2003years.<\/jats:p>","DOI":"10.1111\/j.1365-2141.2007.06873.x","type":"journal-article","created":{"date-parts":[[2007,11,17]],"date-time":"2007-11-17T06:53:51Z","timestamp":1195282431000},"page":"730-743","update-policy":"https:\/\/doi.org\/10.1002\/crossmark_policy","source":"Crossref","is-referenced-by-count":91,"title":["Monoclonal gammopathy of undetermined significance and smouldering multiple myeloma: emphasis on risk factors for progression"],"prefix":"10.1111","volume":"139","author":[{"given":"Robert A.","family":"Kyle","sequence":"first","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"S. Vincent","family":"Rajkumar","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"311","published-online":{"date-parts":[[2007,11,14]]},"reference":[{"key":"e_1_2_14_2_1","doi-asserted-by":"crossref","first-page":"62","DOI":"10.1001\/archinte.1975.00330010064009","article-title":"Monoclonal gammopathy in lymphoma","volume":"135","author":"Alexanian R.","year":"1975","journal-title":"Archives of Internal Medicine"},{"key":"e_1_2_14_3_1","doi-asserted-by":"publisher","DOI":"10.1001\/archinte.162.4.464"},{"key":"e_1_2_14_4_1","doi-asserted-by":"publisher","DOI":"10.1002\/ajh.20157"},{"key":"e_1_2_14_5_1","first-page":"5640","article-title":"High incidence of translocations t(11;14)(q13;q32) and t(4;14)(p16;q32) in patients with plasma cell malignancies","volume":"58","author":"Avet\u2010Loiseau H.","year":"1998","journal-title":"Cancer Research"},{"key":"e_1_2_14_6_1","first-page":"4546","article-title":"14q32 translocations and monosomy 13 observed in monoclonal gammopathy of undetermined significance delineate a multistep process for the oncogenesis of multiple myeloma. Intergroupe Francophone du Myelome","volume":"59","author":"Avet\u2010Loiseau H.","year":"1999","journal-title":"Cancer Research"},{"key":"e_1_2_14_7_1","doi-asserted-by":"crossref","first-page":"2583","DOI":"10.1182\/blood.V94.8.2583.420a05_2583_2589","article-title":"Monosomy 13 is associated with the transition of monoclonal gammopathy of undetermined significance to multiple myeloma. Intergroupe Francophone du Myelome","volume":"94","author":"Avet\u2010Loiseau H.","year":"1999","journal-title":"Blood"},{"key":"e_1_2_14_8_1","doi-asserted-by":"publisher","DOI":"10.1111\/j.0954-6820.1966.tb05453.x"},{"key":"e_1_2_14_9_1","doi-asserted-by":"publisher","DOI":"10.1002\/lt.500020508"},{"key":"e_1_2_14_10_1","doi-asserted-by":"crossref","first-page":"912","DOI":"10.1182\/blood.V87.3.912.bloodjournal873912","article-title":"Role of different hematologic variables in defining the risk of malignant transformation in monoclonal gammopathy","volume":"87","author":"Baldini L.","year":"1996","journal-title":"Blood"},{"key":"e_1_2_14_11_1","doi-asserted-by":"publisher","DOI":"10.1200\/JCO.2005.06.147"},{"key":"e_1_2_14_12_1","doi-asserted-by":"publisher","DOI":"10.1056\/NEJMcp052790"},{"key":"e_1_2_14_13_1","doi-asserted-by":"publisher","DOI":"10.1111\/j.1365-2141.1994.tb05037.x"},{"key":"e_1_2_14_14_1","doi-asserted-by":"publisher","DOI":"10.1111\/j.1365-2141.1992.tb08245.x"},{"key":"e_1_2_14_15_1","doi-asserted-by":"publisher","DOI":"10.1200\/JCO.2002.20.6.1625"},{"key":"e_1_2_14_16_1","doi-asserted-by":"publisher","DOI":"10.3816\/CLM.2005.n.012"},{"key":"e_1_2_14_17_1","doi-asserted-by":"publisher","DOI":"10.1182\/blood-2005-02-0761"},{"key":"e_1_2_14_18_1","doi-asserted-by":"publisher","DOI":"10.1182\/blood.V98.13.3534"},{"key":"e_1_2_14_19_1","doi-asserted-by":"publisher","DOI":"10.1016\/S0190-9622(99)70434-2"},{"key":"e_1_2_14_20_1","doi-asserted-by":"publisher","DOI":"10.1016\/0002-9343(93)90120-E"},{"key":"e_1_2_14_21_1","doi-asserted-by":"publisher","DOI":"10.1053\/j.ajkd.2005.05.004"},{"key":"e_1_2_14_22_1","doi-asserted-by":"publisher","DOI":"10.1182\/blood-2002-07-2299"},{"key":"e_1_2_14_23_1","doi-asserted-by":"publisher","DOI":"10.1016\/0002-9343(92)90749-2"},{"key":"e_1_2_14_24_1","doi-asserted-by":"publisher","DOI":"10.1002\/ajh.2830480201"},{"key":"e_1_2_14_25_1","doi-asserted-by":"publisher","DOI":"10.1182\/blood.V100.4.1417.h81602001417_1417_1424"},{"key":"e_1_2_14_26_1","doi-asserted-by":"publisher","DOI":"10.1158\/1078-0432.CCR-04-1899"},{"key":"e_1_2_14_27_1","doi-asserted-by":"publisher","DOI":"10.1002\/ana.410300111"},{"key":"e_1_2_14_28_1","doi-asserted-by":"publisher","DOI":"10.1002\/(SICI)1096-8652(200001)63:1<1::AID-AJH1>3.0.CO;2-M"},{"key":"e_1_2_14_29_1","doi-asserted-by":"publisher","DOI":"10.1046\/j.1365-2141.2001.02533.x"},{"key":"e_1_2_14_30_1","doi-asserted-by":"publisher","DOI":"10.1016\/S0025-6196(12)65066-6"},{"key":"e_1_2_14_31_1","doi-asserted-by":"publisher","DOI":"10.1016\/S0248-8663(97)80618-2"},{"key":"e_1_2_14_32_1","doi-asserted-by":"publisher","DOI":"10.1046\/j.1365-2141.2003.04355.x"},{"key":"e_1_2_14_33_1","doi-asserted-by":"publisher","DOI":"10.1001\/archinte.161.6.864"},{"key":"e_1_2_14_34_1","doi-asserted-by":"publisher","DOI":"10.1212\/WNL.31.1.24"},{"key":"e_1_2_14_35_1","doi-asserted-by":"publisher","DOI":"10.1182\/blood-2003-11-3811"},{"key":"e_1_2_14_36_1","doi-asserted-by":"publisher","DOI":"10.1200\/JCO.2005.03.159"},{"key":"e_1_2_14_37_1","doi-asserted-by":"publisher","DOI":"10.1016\/0002-9343(78)90522-3"},{"key":"e_1_2_14_38_1","doi-asserted-by":"publisher","DOI":"10.1016\/S0025-6196(12)60015-9"},{"key":"e_1_2_14_39_1","doi-asserted-by":"publisher","DOI":"10.1016\/S0025-6196(12)65225-2"},{"key":"e_1_2_14_40_1","doi-asserted-by":"publisher","DOI":"10.1056\/NEJM198006123022405"},{"key":"e_1_2_14_41_1","doi-asserted-by":"publisher","DOI":"10.1056\/NEJM198203113061002"},{"key":"e_1_2_14_42_1","first-page":"315","volume-title":"Myeloma: Biology and Management","author":"Kyle R.A.","year":"2004"},{"key":"e_1_2_14_43_1","doi-asserted-by":"publisher","DOI":"10.1111\/j.1365-2141.2006.06235.x"},{"key":"e_1_2_14_44_1","doi-asserted-by":"crossref","first-page":"719","DOI":"10.1182\/blood.V40.5.719.719","article-title":"Incidence of monoclonal proteins in a Minnesota community with a cluster of multiple myeloma","volume":"40","author":"Kyle R.A.","year":"1972","journal-title":"Blood"},{"key":"e_1_2_14_45_1","doi-asserted-by":"publisher","DOI":"10.1016\/0002-9343(81)90326-0"},{"key":"e_1_2_14_46_1","doi-asserted-by":"crossref","first-page":"1817","DOI":"10.1182\/blood.V79.7.1817.1817","article-title":"Incidence and natural history of primary systemic amyloidosis, in Olmsted County, Minnesota, 1950 through 1989","volume":"79","author":"Kyle R.A.","year":"1992","journal-title":"Blood"},{"key":"e_1_2_14_47_1","doi-asserted-by":"publisher","DOI":"10.1056\/NEJMoa01133202"},{"key":"e_1_2_14_48_1","doi-asserted-by":"publisher","DOI":"10.4065\/78.1.21"},{"key":"e_1_2_14_49_1","doi-asserted-by":"publisher","DOI":"10.1182\/blood-2003-03-0801"},{"key":"e_1_2_14_50_1","doi-asserted-by":"publisher","DOI":"10.4065\/79.7.859"},{"key":"e_1_2_14_51_1","doi-asserted-by":"publisher","DOI":"10.1056\/NEJMoa054494"},{"key":"e_1_2_14_52_1","doi-asserted-by":"publisher","DOI":"10.1056\/NEJMoa070389"},{"key":"e_1_2_14_53_1","doi-asserted-by":"publisher","DOI":"10.1016\/S1297-319X(01)00343-8"},{"key":"e_1_2_14_54_1","doi-asserted-by":"publisher","DOI":"10.1182\/blood-2005-08-3449"},{"key":"e_1_2_14_55_1","doi-asserted-by":"publisher","DOI":"10.1309\/2A0FL1HM5PN2510P"},{"key":"e_1_2_14_56_1","doi-asserted-by":"publisher","DOI":"10.1177\/107327489800500301"},{"key":"e_1_2_14_57_1","doi-asserted-by":"publisher","DOI":"10.1111\/j.1572-0241.2002.05668.x"},{"key":"e_1_2_14_58_1","doi-asserted-by":"publisher","DOI":"10.1359\/jbmr.0301212"},{"key":"e_1_2_14_59_1","first-page":"350","article-title":"Monoclonal immunoglobulins with antibody activity in myeloma, macroglobulinemia and related plasma cell dyscrasias","volume":"13","author":"Merlini G.","year":"1986","journal-title":"Seminars in Oncology"},{"key":"e_1_2_14_60_1","doi-asserted-by":"publisher","DOI":"10.3816\/CLM.2005.n.013"},{"key":"e_1_2_14_61_1","doi-asserted-by":"crossref","first-page":"619","DOI":"10.1093\/ajcp\/77.5.619","article-title":"Primary hyperparathyroidism and monoclonal gammopathy of undetermined significance","volume":"77","author":"Mundis R.J.","year":"1982","journal-title":"American Journal of Clinical Pathology"},{"key":"e_1_2_14_62_1","doi-asserted-by":"publisher","DOI":"10.1007\/s00415-005-0805-0"},{"key":"e_1_2_14_63_1","doi-asserted-by":"crossref","first-page":"385","DOI":"10.1093\/ajcp\/87.3.385","article-title":"Monoclonal proteins in chronic lymphocytic leukemia","volume":"87","author":"Noel P.","year":"1987","journal-title":"American Journal of Clinical Pathology"},{"key":"e_1_2_14_64_1","doi-asserted-by":"publisher","DOI":"10.1182\/blood-2005-05-1858"},{"key":"e_1_2_14_65_1","doi-asserted-by":"publisher","DOI":"10.1046\/j.1365-2141.2002.03589.x"},{"key":"e_1_2_14_66_1","doi-asserted-by":"publisher","DOI":"10.1016\/0002-9343(87)90659-0"},{"key":"e_1_2_14_67_1","doi-asserted-by":"publisher","DOI":"10.1002\/(SICI)1097-4598(199907)22:7<800::AID-MUS2>3.0.CO;2-F"},{"key":"e_1_2_14_68_1","first-page":"2210","article-title":"Bone marrow angiogenesis in 400 patients with monoclonal gammopathy of undetermined significance, multiple myeloma, and primary amyloidosis","volume":"8","author":"Rajkumar S.V.","year":"2002","journal-title":"Clinical Cancer Research"},{"key":"e_1_2_14_69_1","doi-asserted-by":"publisher","DOI":"10.1046\/j.1365-2141.2002.03912.x"},{"key":"e_1_2_14_70_1","doi-asserted-by":"publisher","DOI":"10.1182\/blood-2005-03-1038"},{"key":"e_1_2_14_71_1","doi-asserted-by":"publisher","DOI":"10.4065\/81.5.693"},{"key":"e_1_2_14_72_1","doi-asserted-by":"publisher","DOI":"10.1182\/blood-2004-03-0833"},{"key":"e_1_2_14_73_1","first-page":"227","volume-title":"Hematology 2002: American Society of Hematology Education Program Book","author":"Roodman G.D.","year":"2002"},{"key":"e_1_2_14_74_1","doi-asserted-by":"publisher","DOI":"10.1046\/j.1365-2141.2003.04654.x"},{"key":"e_1_2_14_75_1","doi-asserted-by":"publisher","DOI":"10.4065\/82.4.428"},{"key":"e_1_2_14_76_1","doi-asserted-by":"publisher","DOI":"10.1159\/000168712"},{"key":"e_1_2_14_77_1","doi-asserted-by":"publisher","DOI":"10.1136\/jcp.35.1.63"},{"key":"e_1_2_14_78_1","doi-asserted-by":"publisher","DOI":"10.1093\/annonc\/mdh385"},{"key":"e_1_2_14_79_1","volume-title":"SEER*Stat Database: Incidence \u2010 SEER 9 Regs Public Use","author":"Surveillance, Epidemiology, and End Results (SEER) Program","year":"2005"},{"key":"e_1_2_14_80_1","doi-asserted-by":"publisher","DOI":"10.1158\/1078-0432.CCR-03-0716"},{"key":"e_1_2_14_81_1","doi-asserted-by":"publisher","DOI":"10.1002\/ajh.10338"},{"key":"e_1_2_14_82_1","doi-asserted-by":"publisher","DOI":"10.1111\/j.1365-2141.1994.tb08304.x"},{"key":"e_1_2_14_83_1","first-page":"398","article-title":"Abnormal proteins in myeloma","volume":"5","author":"Waldenstr\u00f6m J.","year":"1952","journal-title":"Advances in Internal Medicine"},{"key":"e_1_2_14_84_1","doi-asserted-by":"publisher","DOI":"10.1046\/j.1365-2141.1997.1122939.x"},{"key":"e_1_2_14_85_1","doi-asserted-by":"crossref","first-page":"3518","DOI":"10.1182\/blood.V91.9.3518","article-title":"Oligoclonal protein bands and Ig isotype switching in multiple myeloma treated with high\u2010dose therapy and hematopoietic cell transplantation","volume":"91","author":"Zent C.S.","year":"1998","journal-title":"Blood"}],"container-title":["British Journal of Haematology"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.wiley.com\/onlinelibrary\/tdm\/v1\/articles\/10.1111%2Fj.1365-2141.2007.06873.x","content-type":"unspecified","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/onlinelibrary.wiley.com\/doi\/pdf\/10.1111\/j.1365-2141.2007.06873.x","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2023,10,13]],"date-time":"2023-10-13T23:02:36Z","timestamp":1697238156000},"score":1,"resource":{"primary":{"URL":"https:\/\/onlinelibrary.wiley.com\/doi\/10.1111\/j.1365-2141.2007.06873.x"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2007,11,14]]},"references-count":84,"journal-issue":{"issue":"5","published-print":{"date-parts":[[2007,12]]}},"alternative-id":["10.1111\/j.1365-2141.2007.06873.x"],"URL":"https:\/\/doi.org\/10.1111\/j.1365-2141.2007.06873.x","archive":["Portico"],"relation":{},"ISSN":["0007-1048","1365-2141"],"issn-type":[{"value":"0007-1048","type":"print"},{"value":"1365-2141","type":"electronic"}],"subject":[],"published":{"date-parts":[[2007,11,14]]},"assertion":[{"value":"2007-11-14","order":2,"name":"published","label":"Published","group":{"name":"publication_history","label":"Publication History"}}]}}